Also trades as: CPH.TO (TSX) · $vol 0M
CPHRF OTC
Cipher Pharmaceuticals Inc.
1W: -2.4%
1M: -8.1%
3M: -19.4%
YTD: -11.4%
1Y: -14.2%
3Y: +197.2%
5Y: +441.0%
$9.63
+0.06 (+0.60%)
Weekly Expected Move ±2.9%
$9
$9
$10
$10
$10
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$156M
-3.9% ▼
5Y CAGR: +28.7%
Total Liabilities
$30M
-49.8% ▼
5Y CAGR: +21.0%
Shareholders Equity
$126M
+23.1% ▲
5Y CAGR: +31.0%
Cash & Investments
$7M
-58.1% ▼
5Y CAGR: -3.9%
Total Debt
$5M
-86.5% ▼
5Y CAGR: +24.3%
Net Debt
-$2M
-108.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $21M | $29M | $40M | $18M | $7M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $21M | $29M | $40M | $18M | $7M |
| Net Receivables | $7M | $7M | $5M | $14M | $11M |
| Inventory | $2M | $2M | $3M | $6M | $8M |
| Other Current Assets | $0 | $0 | $378K | $995K | $1M |
| Total Current Assets | $29M | $38M | $48M | $38M | $28M |
| Property, Plant & Equip. | $501K | $481K | $402K | $680K | $568K |
| Goodwill & Intangibles | $19M | $18M | $17M | $96M | $89M |
| Long-Term Investments | $20M | $19M | $0 | $0 | $0 |
| Other Non-Current Assets | -$20M | -$19M | $0 | $386K | $236K |
| Total Non-Current Assets | $22M | $36M | $38M | $124M | $128M |
| Total Assets | $52M | $74M | $86M | $163M | $156M |
| — Liabilities — | |||||
| Accounts Payable | $6M | $4M | $5M | $6M | $6M |
| Short-Term Debt | $0 | $0 | $0 | $283K | $288K |
| Deferred Revenue | $450K | $257K | $519K | $13M | $0 |
| Other Current Liabilities | $7M | $5M | $0 | -$275K | $18M |
| Total Current Liabilities | $12M | $9M | $5M | $20M | $25M |
| Long-Term Debt | $0 | $0 | $0 | $40M | $5M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $460K | $327K | $259K | $40M | $5M |
| Total Liabilities | $13M | $10M | $6M | $60M | $30M |
| — Equity — | |||||
| Common Stock | $18M | $18M | $18M | $28M | $28M |
| Retained Earnings | $25M | $51M | $66M | $78M | $100M |
| Accumulated OCI | -$10M | -$10M | -$10M | -$10M | -$9M |
| Total Stockholders Equity | $39M | $64M | $81M | $102M | $126M |
| Total Liabilities & Equity | $52M | $74M | $86M | $163M | $156M |
| — Key Metrics — | |||||
| Total Debt | $516K | $428K | $353K | $41M | $5M |
| Net Debt | -$20M | -$28M | -$39M | $23M | -$2M |
| Total Investments | $20M | $19M | $0 | $0 | $0 |